Hematopoietic Stem Cell Stocks List

Recent Signals

Date Stock Signal Type
2021-05-05 ATNM Bollinger Band Squeeze Range Contraction
2021-05-05 BLCM 20 DMA Support Bullish
2021-05-05 CBLI 20 DMA Resistance Bearish
2021-05-05 CMRX Bollinger Band Squeeze Range Contraction
2021-05-05 CO NR7-2 Range Contraction
2021-05-05 CO NR7 Range Contraction
2021-05-05 CO Upper Bollinger Band Walk Strength
2021-05-05 FATE MACD Bearish Signal Line Cross Bearish
2021-05-05 FATE MACD Bearish Centerline Cross Bearish
2021-05-05 HGEN Expansion Pivot Buy Setup Bullish Swing Setup
2021-05-05 HGEN Pocket Pivot Bullish Swing Setup
2021-05-05 NTLA 20 DMA Resistance Bearish
2021-05-05 NTLA Spinning Top Other

Recent News for Hematopoietic Stem Cell Stocks

Date Stock Title
May 5 FATE Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
May 5 HGEN This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
May 5 FIXX Homology Medicines (FIXX) Investor Presentation - Slideshow
May 5 FATE Fate Therapeutics EPS misses by $0.05, beats on revenue
May 5 FATE Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress
May 5 NTLA Intellia Therapeutics Q1 2021 Earnings Preview
May 5 HGEN Humanigen is on the rise after publication of Phase 3 data for COVID-19 therapy
May 5 HGEN Humanigen Announces Publication of Results From Phase 3 Randomized Double-Blind Placebo-Controlled Study Demonstrating the Efficacy and Safety of Lenzilumab™ in Hospitalized COVID-19 Patients
May 5 CMRX Chimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy?
May 4 FATE Fate Therapeutics Q1 2021 Earnings Preview
May 4 NTLA Intellia and Sangamo preferred as RBC extends gene editing coverage
May 3 FIXX Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
May 2 NTLA Intellia Expands Its In Vivo Advantage
May 1 NTLA Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Apr 30 NTLA 3 Exciting Biotech Stocks to Buy Right Now
Apr 29 FIXX Will Homology Medicines (FIXX) Report Negative Q1 Earnings? What You Should Know
Apr 29 NTLA Analysts Estimate Intellia Therapeutics, Inc. (NTLA) to Report a Decline in Earnings: What to Look Out for
Apr 29 FATE Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2021 Financial Results
Apr 29 NTLA Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2021 Earnings and Company Updates
Apr 29 CMRX Chimerix to Report First Quarter 2021 Financial Results and Provide an Operational Update on May 6, 2021
Related Industries: Biotechnology